Status:
COMPLETED
A Trial to Evaluate Natural Orifice Transvaginal Endoscopic Cholecystectomy With Laparoscopic Assistance
Lead Sponsor:
Ethicon Endo-Surgery
Conditions:
Gallbladder Disease
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The study will document being able to successfully remove a subject's gallbladder through the vagina (laparoscopic visualization)using a small collection of study surgical tools.
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Women will be enrolled in this study who:
- Are willing to give consent and comply with evaluation and treatment schedule, able to understand and complete study questionnaires;
- At least 18 years of age;
- Have a clinical diagnosis of gallbladder disease indicated for cholecystectomy;
- ASA Classification I or II (Appendix II);
- Have a negative serum pregnancy test (for women of childbearing potential); and
- Absence, on visual inspection, of adhesions judged to be a potentially complicating factor in transvaginal access and operation.
- Exclusion Criteria
- Subjects will be excluded from the study for any of the following:
- BMI \> 35;
- Use of immunosuppressive medications (within 6 months of surgery; single burst dosages and inhalable steroids are acceptable);
- Suspicion of gallbladder cancer, tumor, polyps, or mass;
- Acute cholecystitis or acute pancreatitis;
- Presence of common bile duct stones;
- History of cervical or vaginal cancer (or precancerous findings on most recent Pap Test);
- Pelvic Inflammatory Disease;
- Evidence of abdominal abscess or mass;
- Diffuse peritonitis;
- Use of anticoagulants or anti-platelet agents (use of daily cardio protective doses of aspirin, up to 81 mg/day, is acceptable and shall not constitute an exclusion criterion) or the presence of coagulopathy;
- Clinical diagnosis of sepsis;
- History of ectopic pregnancy, pelvic inflammatory disease, or severe endometriosis;
- History of peritoneal or vaginal trauma;
- Co-morbid condition(s) that could limit the subject's ability to participate in the study or to comply with follow-up requirements, or that could impact the scientific integrity of the trial;
- Planned concurrent surgical procedure;
- Prior or planned major surgical procedure within 30 days before or after study procedure;
- History of transvaginal surgery;
- History of (or symptomatic for) abdominal adhesions;
- Participation in any other investigational device or drug trial that has not completed the primary endpoint or that clinically interferes with the current study endpoints;
- Previously enrolled in the current series of 4 trials investigating the EES NOTES GEN1 Toolbox;
- Any contraindication listed in a study device Instructions for Use (IFU) document (if that device may be used in the study procedure); or
- Any condition which precludes compliance with the study (Investigator discretion).
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00889928
Start Date
April 1 2009
End Date
August 1 2011
Last Update
November 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University Feinberg School of Medicine - ATTN: Dr Hungness
Chicago, Illinois, United States, 60611